<?xml version="1.0" encoding="UTF-8"?>
<p id="Par20">Patient 2 was a 15-year-old male also diagnosed as B-ALL (CD19+, BCR/ABL-) in October, 2014 (Fig. 
 <xref rid="Fig4" ref-type="fig">4a</xref>). He underwent allo-HSCT from his 10/10 HLA allele-matched sibling in June, 2015, and unfortunately had a relapse in CNS 6 months later. Then, he achieved a second CR after intrathecal chemotherapy (IT), irradiation, and donor lymphocyte infusion (DLI). However, the leukemia recurred again 10 months later with BM and extramedullary involvement. The BM smear showed typical leukemic blasts account for 15% (Fig. 
 <xref rid="Fig4" ref-type="fig">4b</xref>). The PET/CT revealed that an abnormal intense high metabolic region beneath the kidney capsule, indicating the extramedullary relapse in kidney (Fig. 
 <xref rid="Fig4" ref-type="fig">4c</xref>). Although he received chemotherapy regimen of VDLCP, he had no response at all.
</p>
